ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SI vs CLPT // ALTMAN Z-SCORE & DEBT/EQUITY

Shoulder Innovations Inc. (NYSE) VS. ClearPoint Neuro Inc. (NASDAQ) • 15-METRIC TALLY: SI 8 — CLPT 1
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: SI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SI VS. CLPT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SI CLPT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.50% 61.40% +15.10 SI /gross-margins <GO>
Return on Invested Capital (ROIC) -16.10% -35.00% +18.90 SI /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.46% -7.13% -1.33 CLPT /fcf-yield <GO>
Operating Margin -55.60% -60.00% +4.40 SI /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 49.60% 17.80% +31.80 SI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 8.73 0.20 +8.53 SI /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 SI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.0 48.9 +1.10 SI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $398.3M $342.0M $56.2M SI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SI REV CLPT REV SI GROSS % CLPT GROSS % SI FCF CLPT FCF
FY 2025 $47.3M $37.0M 76.5% 61.4% -$36.0M -$24.4M
FY 2024 $31.6M $31.4M 77.0% 60.9% -$18.2M -$9.2M
FY 2023 — $24.0M — — — -$13.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SI // BETA —
CLPT // BETA —